Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Clin Transl Oncol. 2024 Mar 21. doi: 10.1007/s12094-024-03404-9. Online ahead of print.
Clin Transl Oncol. 2024.
PMID: 38512450
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Postel-Vinay S, Coves J, Texier M, Aldea M, Gazzah A, Dómine M, Planchard D, De Las Peñas R, Sala Gonzalez MA, Viteri S, Perez J, Ortega AL, Moran T, Camps C, Lopez-Martin A, Provencio M, Soria JC, Besse B, Massuti B, Rosell R.
Postel-Vinay S, et al. Among authors: sala gonzalez ma.
Br J Cancer. 2024 Feb;130(3):417-424. doi: 10.1038/s41416-023-02514-5. Epub 2023 Dec 14.
Br J Cancer. 2024.
PMID: 38097741
Clinical Trial.
Item in Clipboard
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
Candal-Pedreira C, Ruano-Ravina A, Calvo de Juan V, Cobo M, Trigo JM, Carcereny E, Cucurull M, López Castro R, Solís García E, Sánchez-Gastaldo A, Massutí B, Rodríguez-Abreu D, Estival A, Guirado Risueño M, Pamiés Ramón M, García Campelo R, Alonso-Jáudenes G, Camps C, Del Barco Morillo E, González Ojea C, Dómine M, Sanchez-Hernandez A, Bosch-Barrera J, Sala González MÁ, Provencio M.
Candal-Pedreira C, et al. Among authors: sala gonzalez ma.
ERJ Open Res. 2023 Dec 4;9(6):00468-2023. doi: 10.1183/23120541.00468-2023. eCollection 2023 Nov.
ERJ Open Res. 2023.
PMID: 38076676
Free PMC article.
Item in Clipboard
Changes in lung cancer survival by TNM stage in the Basque country from 2003 to 2014 according to period of diagnosis.
Mar J, Arrospide A, Iruretagoiena ML, Clèries R, Paredes A, Elejoste I, Sala-Gonzalez MA, Ibarrondo O.
Mar J, et al. Among authors: sala gonzalez ma.
Cancer Epidemiol. 2020 Apr;65:101668. doi: 10.1016/j.canep.2020.101668. Epub 2020 Jan 8.
Cancer Epidemiol. 2020.
PMID: 31926455
Item in Clipboard
Prolonged survival with erlotinib followed by afatinib in a caucasian smoker with metastatic, poorly differentiated large cell carcinoma of the lung: a case report.
Sala González MÁ.
Sala González MÁ.
Cancer Biol Ther. 2015;16(10):1434-7. doi: 10.1080/15384047.2015.1070993. Epub 2015 Jul 17.
Cancer Biol Ther. 2015.
PMID: 26186355
Free PMC article.
Item in Clipboard
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.
Davies C, et al.
Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1.
Lancet. 2013.
PMID: 23219286
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite